OBJECTIVE:Contingency management (CM) is an empirically validated treatment for substance use disorders, but its effects on psychiatric symptoms have not been systematically examined. The purpose of this study was to examine the impact of CM on psychiatric symptoms of cocaine dependent patients receiving CM with standard care versus standard care alone. METHOD:Psychiatric symptoms were evaluated in 393 patients participating in 1 of 3 randomized trials ofCM at treatment initiation and 1, 3 (posttreatment), 6, and 9 months later. RESULTS: Patients randomized to CM evidenced significant reductions in psychiatric symptoms over time throughout the 9-month follow-up. In contrast, psychiatric symptoms remained stable relative to baseline in patients randomized to standard care. A significant time by treatment condition effect was noted (p < .05) for overall psychiatric distress as well as for specific indices of depression, hostility, interpersonal sensitivity, phobic anxiety and psychoticism symptoms. Reductions in drug use mediated the effects of CM on psychiatric symptoms. CONCLUSIONS: These data demonstrate that the effects of CM extend beyond their impact on drug use behaviors and the period in which reinforcers are in effect. (c) 2013 APA, all rights reserved.
RCT Entities:
OBJECTIVE: Contingency management (CM) is an empirically validated treatment for substance use disorders, but its effects on psychiatric symptoms have not been systematically examined. The purpose of this study was to examine the impact of CM on psychiatric symptoms of cocaine dependent patients receiving CM with standard care versus standard care alone. METHOD:Psychiatric symptoms were evaluated in 393 patients participating in 1 of 3 randomized trials of CM at treatment initiation and 1, 3 (posttreatment), 6, and 9 months later. RESULTS:Patients randomized to CM evidenced significant reductions in psychiatric symptoms over time throughout the 9-month follow-up. In contrast, psychiatric symptoms remained stable relative to baseline in patients randomized to standard care. A significant time by treatment condition effect was noted (p < .05) for overall psychiatric distress as well as for specific indices of depression, hostility, interpersonal sensitivity, phobic anxiety and psychoticism symptoms. Reductions in drug use mediated the effects of CM on psychiatric symptoms. CONCLUSIONS: These data demonstrate that the effects of CM extend beyond their impact on drug use behaviors and the period in which reinforcers are in effect. (c) 2013 APA, all rights reserved.
Authors: Geoffrey M Curran; JoAnn E Kirchner; Mark Worley; Craig Rookey; Brenda M Booth Journal: J Behav Health Serv Res Date: 2002-05 Impact factor: 1.505
Authors: Stephen T Higgins; Stacey C Sigmon; Conrad J Wong; Sarah H Heil; Gary J Badger; Robert Donham; Robert L Dantona; Stacey Anthony Journal: Arch Gen Psychiatry Date: 2003-10
Authors: Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan Journal: Arch Gen Psychiatry Date: 2004-08
Authors: André Q C Miguel; Brian D Kiluk; Theresa A Babuscio; Charla Nich; Jair J Mari; Kathleen M Carroll Journal: Drug Alcohol Depend Date: 2019-03-20 Impact factor: 4.492
Authors: André Q C Miguel; Clarice S Madruga; Hugo Cogo-Moreira; Rodolfo Yamauchi; Viviane Simões; Ariadne Ribeiro; Claudio J da Silva; Andrew Fruci; Michael McDonell; Sterling McPherson; John M Roll; Ronaldo R Laranjeira Journal: Exp Clin Psychopharmacol Date: 2017-12 Impact factor: 3.157